Ketamine attenuates early lipopolysaccharide-induced gastric dysfunction: Role of stress-inducible phosphoproteins

Journal of Trauma - Injury, Infection and Critical Care

Volumn 62, Issue 2, 2007, Pages 316-319

  Suliburk, James W ^a   Mercer, David W ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

IkB alpha; JNK; Ketamine; LPS; p38; Stomach

Indexed keywords

ENDOTOXIN; I KAPPA B ALPHA; KETAMINE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOPROTEIN; SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOASSAY; INFLAMMATION; MALE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; STOMACH DISEASE; STOMACH JUICE; STOMACH MUCOSA; STOMACH VOLUME; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY FLUIDS; GASTRIC EMPTYING; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRANSIT; HYDROGEN-ION CONCENTRATION; I-KAPPA B KINASE; KETAMINE; LIPOPOLYSACCHARIDES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 14; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 33846946824     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/01.ta.0000221755.84832.55     Document Type: Article

References (24)

1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-150.
2. Ciesla DJ, Moore EE, Johnson JL, Burch JM, Cothren CC, Sauaia A. A 12-year prospective study of postinjury multiple organ failure: has anything changed? Arch Surg. 2005;140:432-438; discussion, 438-440.
3. Heyland D, Mandell LA. Gastric colonization by gram-negative bacilli and nosocomial pneumonia in the intensive care unit patient. Evidence for causation. Chest. 1992;101:187-193.
4. Mentec H, Dupont H, Bocchetti M, Cani P, Ponche F, Bleichner G. Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications. Crit Care Med. 2001;29:1955-1961.
5. Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA. Post-injury multiple organ failure: the role of the gut. Shock. 2001;15:1-10.
6. Helmer KS, West SD, Shipley GL, et al. Gastric nitric oxide synthase expression during endotoxemia: implications in mucosal defense in rats. Gastroenterology. 2002;123:173-186.
7. Dial EJ, Romero JJ, Villa X, Mercer DW, Lichtenberger LM. Lipopolysaccharide-induced gastrointestinal injury in rats: role of surface hydrophobicity and bile salts. Shock. 2002;17:77-80.
8. West SD, Suliburk JW, Smith GS, Mercer DW. Effects of lipopolysaccharide on gastric stasis: role of cyclo-oxygenase. Dig Dis Sci. 2006;51:754-765.
9. Taniguchi T, Shibata K, Yamamoto K. Ketamine inhibits endotoxin-induced shock in rats. Anesthesiology. 2001;95:928-932.
10. Suliburk JW, Gonzalez EA, Kennison SD, Helmer KS, Mercer DW. Differential effects of anesthetics on endotoxin-induced liver injury. J Trauma. 2005;58:711-716; discussion, 716-717.
11. Grishin A, Wang J, Hackam D, et al. p38 MAP kinase mediates endotoxin-induced expression of cyclooxygenase-2 in enterocytes. Surgery. 2004;136:329-335.
12. Slomiany BL, Slomiany A. Role of ERK and p38 mitogen-activated protein kinase cascades in gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. IUBMB Life. 2001;51:315-320.
13. Castaneda AA, Denning JW, Chang L, Mercer DW. Does upregulation of inducible nitric oxide synthase (iNOS) render the stomach more susceptible to damage? J Surg Res. 1999;84:174-179.
14. Nguyen A, Yaffe MB. Proteomics and systems biology approaches to signal transduction in sepsis. Crit Care Med. 2003;31(1 Suppl):S1-6.
15. Helmer KS, Cui Y, Chang L, Dewan A, Mercer DW. Effects of ketamine/xylazine on expression of tumor necrosis factor-alpha, inducible nitric oxide synthase, and cyclo-oxygenase-2 in rat gastric mucosa during endotoxemia. Shock. 2003;20:63-69.
16. Sun J, Wang XD, Liu H, Xu JG. Ketamine suppresses endotoxin-induced NF-kappaB activation and cytokines production in the intestine. Acta Anaesthesiol Scand. 2004;48:317-321.
17. Takenaka I, Ogata M, Koga K, Matsumoto T, Shigematsu A. Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice. Anesthesiology. 1994;80:402-408.
18. Adams HA. [S-(+)-ketamine. Circulatory interactions during total intravenous anesthesia and analgesia-sedation]. Anaesthesist. 1997;46:1081-1087.
19. Taniguchi T, Takemoto Y, Kanakura H, Kidani Y, Yamamoto K. The dose-related effects of ketamine on mortality and cytokine responses to endotoxin-induced shock in rats. Anesth Analg. 2003;97:1769-1772.
20. Sun J, Zhou ZQ, Lv R, Li WY, Xu JG. Ketamine inhibits LPS-induced calcium elevation and NF-kappa B activation in monocytes. Inflamm Re. 2004;53:304-308.
21. Suliburk JW, Helmer KS, Gonzalez EA, Robinson EK, Merar DW. Ketamine attenuates liver injury due to endotoxemia: role of cyclooxygenase-2. Surgery. 2005;138:134-140.
22. Elia N, Tramer MR. Ketamine and postoperative pain-a quantitative systematic review of randomised trials. Pain. 2005;113:61-70.
23. Jacobs DG, Jacobs DO, Kudsk KA, et al. Practice management guidelines for nutritional support of the trauma patient. J Trauma. 2004;57:660-678; discussion, 679.
24. Heyland DK, Dhaliwal R, Day A, Jain M, Drover J. Validation of the Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients: results of a prospective observational study. Crit Care Med. 2004;32:2260-2266.